<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Squamous cell carcinoma of the skin (SCCs) accounts for 20-30% of non-melanoma skin cancers, resulting in 1 million cases in the United States annually. The risk of developing SCCs increases annually, and this process will likely be continued because of the aging population. We investigated 355 patients with histopathologically confirmed SCCs. We rated the age- and sex-related incidence, risk factors, localisation, pathological features, staging systems and treatment, and the recurrence and mortality rates of the tumours. Staging and risk stratification for recurrence and metastases is significant. Most SCCs are successfully treated surgically, with a small subset of carcinomas leading to recurrence, metastasis, and death. Patients with advanced and metastatic disease are often inappropriate for surgical and radiation therapy. We present the first study on squamous cell carcinoma of the skin conducted for the population of the Pleven and Lovech regions of Bulgaria.</p>
</abstract>

Squamous cell carcinoma of the skin (SCCs) accounts for 20-30% of non-melanoma skin cancers, resulting in 1 million cases in the United States annually. The risk of developing SCCs increases annually, and this process will likely be continued because of the aging population. We investigated 355 patients with histopathologically confirmed SCCs. We rated the age- and sex-related incidence, risk factors, localisation, pathological features, staging systems and treatment, and the recurrence and mortality rates of the tumours. Staging and risk stratification for recurrence and metastases is significant. Most SCCs are successfully treated surgically, with a small subset of carcinomas leading to recurrence, metastasis, and death. Patients with advanced and metastatic disease are often inappropriate for surgical and radiation therapy. We present the first study on squamous cell carcinoma of the skin conducted for the population of the Pleven and Lovech regions of Bulgaria.

Squamous Cell Carcinoma of the Skin: Epidemiology, Diagnosis, Management, Recurrence and Mortality Rates for the Bulgarian Population

Department of Dermatology, Venereology and Allergology, Dr Georgi Stranski University Hospital, Faculty of Medicine

Department of General and Clinical Pathology, Faculty of Medicine

Surgical Oncology Department, Dr Georgi Stranski University Hospital, Faculty of Medicine

Department of Nuclear Medicine, Radiation Therapy and Medical Oncology, Tsaritsa Yoanna University Hospital, Faculty of Medicine

Journal of Biomedical and Clinical Research

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Squamous cell carcinoma of the skin (SCCs) accounts for 20-30% of non-melanoma skin cancers, resulting in 1 million cases in the United States annually. The...

Squamous Cell Carcinoma of the Skin: Epidemiology, Diagnosis, Management, Recurrence and Mortality Rates for the Bulgarian Population

Publicado en línea: 11 dic 2023

Páginas: 180 - 185

Recibido: 03 may 2023

Aceptado: 16 nov 2023

DOI: https://doi.org/10.2478/jbcr-2023-0024

Palabras clave
squamous cell carcinoma of the skin, epidemiology, treatment, recurrence, mortality

© 2023 Preslav P. Vasilev et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Squamous Cell Carcinoma of the Skin: Epidemiology, Diagnosis, Management, Recurrence and Mortality Rates for the Bulgarian Population

Publicado en línea: 11 dic 2023

Páginas: 180 - 185

Recibido: 03 may 2023

Aceptado: 16 nov 2023

DOI: https://doi.org/10.2478/jbcr-2023-0024

Palabras clavesquamous cell carcinoma of the skin, epidemiology, treatment, recurrence, mortality

© 2023 Preslav P. Vasilev et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Palabras clave
squamous cell carcinoma of the skin, epidemiology, treatment, recurrence, mortality